EP Patent

EP1740186A1 — Biodegradable intraocular implants containing prostamides

Assigned to Allergan Inc · Expires 2007-01-10 · 19y expired

What this patent protects

The present invention relates to microspheres comprising: a prostamide component and a biodegradable polymer matrix. The invention also relates to biodegradable intraocular implants.

USPTO Abstract

The present invention relates to microspheres comprising: a prostamide component and a biodegradable polymer matrix. The invention also relates to biodegradable intraocular implants.

Drugs covered by this patent

Patent Metadata

Patent number
EP1740186A1
Jurisdiction
EP
Classification
—
Expires
2007-01-10
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.